Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
LIMN: Liminatus Pharma, Inc. Class A Common Stock Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
LIMN
The Story
LIMN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-283.2%
Financially safe
Stretched
Debt / equity
-10.88×
Interest coverage
-32.0×
Current ratio
0.96×
Liminatus Pharma, Inc. Class A Common Stock
LIMN
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Liminatus Pharma, Inc. Class A Common Stock
LIMN
NASDAQ
·
USD
·
Closed
$0.10
+0.88%
$0.10
+$0.00 (0.88%)
52W Range
0th
pctl
Volume
0.15×
avg
Mkt Cap
2.76M
USD
P/E
-0.3
TTM
Div Yield
–
ann
52W Range
0th
pctl
Volume
0.15×
avg
Market Cap
2.76M
USD
P/E Ratio
-0.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings